AU Patent

AU2021266232B1 — Nitrile-containing antiviral compounds

Assigned to Pfizer Inc · Expires 2022-02-03 · 4y expired

What this patent protects

OF THE INVENTION The invention relates to compounds of Formula I" 0 NH S)q' R2 R) R3 N N Y H 0 R1 I", wherein R, R1, R2, R 3, p, q and q'are as defined herein, pharmaceutical compositions comprising the compounds, methods of treating coronavirus infection suc…

USPTO Abstract

OF THE INVENTION The invention relates to compounds of Formula I" 0 NH S)q' R2 R) R3 N N Y H 0 R1 I", wherein R, R1, R2, R 3, p, q and q'are as defined herein, pharmaceutical compositions comprising the compounds, methods of treating coronavirus infection such as COVID 19 in a patient by administering therapeutically effective amounts of the compounds, and methods of inhibiting or preventing replication of coronaviruses such as SARS CoV-2 with the compounds. R17

Drugs covered by this patent

Patent Metadata

Patent number
AU2021266232B1
Jurisdiction
AU
Classification
—
Expires
2022-02-03
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.